Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01306890 · ClinicalTrials.gov registry record
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
A clinical trial, sponsored by Dendreon.
- Completed
- Registry status
- 1,976
- Enrollment target
NCT01306890 is a clinical trial that has completed, run by Dendreon. The registered enrollment target is 1,976 participants.
The verdict
NCT01306890 has completed, sponsored by Dendreon.
- COMPLETED
- Registry status
- 1,976 participants
- Enrollment target
Study Summary
The purpose of this study is to further quantify the risk of cerebrovascular events (CVEs) following sipuleucel-T (PROVENGE®) therapy, and to follow all subjects for survival.
Interventions
- BIOLOGICAL sipuleucel-T
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,976 participants |
| Start Date | 2011-01-27 |
| Est. Completion | 2017-01-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01306890
The ClinicalTrials.gov registry entry for NCT01306890 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,976 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dendreon, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which sipuleucel-T is the first listed.
NCT01306890 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01306890 about?
NCT01306890 is a clinical study titled "A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer". The purpose of this study is to further quantify the risk of cerebrovascular events (CVEs) following sipuleucel-T (PROVENGE®) therapy, and to follow all subjects for survival.
What is the current status of trial NCT01306890?
This trial is currently completed. The enrollment target is 1,976 participants. The study started on 2011-01-27. Estimated completion is 2017-01-17.
What interventions are being tested in trial NCT01306890?
The interventions under investigation include: sipuleucel-T (BIOLOGICAL).
Who is sponsoring clinical trial NCT01306890?
This trial is sponsored by Dendreon, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.